Price$9.32-2.76 (-22.81%)
2026-03-052026-06-08
News · 26 weeks100-50%
2025-12-142026-06-07
Mix6090d
- Insider30(50%)
- SEC Filings11(18%)
- Analyst9(15%)
- Other6(10%)
- Earnings3(5%)
- Leadership1(2%)
Latest news
25 items- SECSEC Form 10-Q filed by Phreesia Inc.10-Q - Phreesia, Inc. (0001412408) (Filer)
- ANALYSTPhreesia downgraded by Piper Sandler with a new price targetPiper Sandler downgraded Phreesia from Overweight to Neutral and set a new price target of $12.00
- PRPhreesia Announces First Quarter Fiscal 2027 ResultsPhreesia, Inc. (NYSE:PHR) ("Phreesia" or the "Company") announced financial results today for the fiscal first quarter ended April 30, 2026. "Phreesia had a solid first quarter to build on in fiscal 2027. We entered the new fiscal year with an experienced team, a strong financial profile and continued momentum across several key initiatives, including positioning AccessOne for future growth, the successful launch of our healthcare provider (HCP) marketing offerings and the infusion of AI into the Phreesia operating model," said CEO and Co-Founder Chaim Indig. Please visit the Phreesia investor relations website at ir.phreesia.com to view the Company's Q1 Fiscal 2027 Stakeholder Letter.
- SECPhreesia Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits8-K - Phreesia, Inc. (0001412408) (Filer)
- INSIDERPrincipal Accounting Officer Hui Yvonne sold $3,814 worth of shares (431 units at $8.85) as part of a pre-agreed trading plan and covered exercise/tax liability with 325 shares, decreasing direct ownership by 3% to 23,908 units (SEC Form 4) (for tax liability)4 - Phreesia, Inc. (0001412408) (Issuer)
- ANALYSTPhreesia downgraded by Wells Fargo with a new price targetWells Fargo downgraded Phreesia from Overweight to Equal Weight and set a new price target of $9.00
- ANALYSTPhreesia downgraded by Barclays with a new price targetBarclays downgraded Phreesia from Overweight to Equal Weight and set a new price target of $10.00
- SECSEC Form DEFA14A filed by Phreesia Inc.DEFA14A - Phreesia, Inc. (0001412408) (Filer)
- SECSEC Form DEF 14A filed by Phreesia Inc.DEF 14A - Phreesia, Inc. (0001412408) (Filer)
- SECPhreesia Inc. filed SEC Form 8-K: Other Events8-K - Phreesia, Inc. (0001412408) (Filer)
- INSIDERDirector Cahill Edward L was granted 1,085 shares, increasing direct ownership by 2% to 65,613 units (SEC Form 4)4 - Phreesia, Inc. (0001412408) (Issuer)
- INSIDERDirector Goldstein Lainie was granted 1,085 shares, increasing direct ownership by 2% to 51,195 units (SEC Form 4)4 - Phreesia, Inc. (0001412408) (Issuer)
- INSIDERDirector Munson Gillian was granted 1,085 shares, increasing direct ownership by 2% to 46,814 units (SEC Form 4)4 - Phreesia, Inc. (0001412408) (Issuer)
- SECPhreesia Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Financial Statements and Exhibits8-K - Phreesia, Inc. (0001412408) (Filer)
- PRPhreesia Sets Release Date for Fiscal First Quarter 2027 ResultsPhreesia, Inc. (NYSE:PHR) ("Phreesia") today announced that it will release its fiscal first quarter 2027 financial results after the close of market trading on Wednesday, May 27, 2026. Phreesia will issue a press release announcing its quarterly results and the company's quarterly stakeholder letter, both of which will be posted on its investor website at ir.phreesia.com. Phreesia will then hold a conference call to discuss its fiscal first quarter results starting at 5PM Eastern Time on the same day. To participate in the company's live conference call and webcast, please dial (833) 461-5787, or (626) 884-3620 for international participants, using conference code number 953036497, or vi
- INSIDERSEC Form 4 filed by Hui Yvonne4 - Phreesia, Inc. (0001412408) (Issuer)
- INSIDERSEC Form 4 filed by Hoffman Allison C4 - Phreesia, Inc. (0001412408) (Issuer)
- INSIDERSEC Form 4 filed by Linetsky David4 - Phreesia, Inc. (0001412408) (Issuer)
- INSIDERSEC Form 4 filed by Hui Yvonne4 - Phreesia, Inc. (0001412408) (Issuer)
- PRPhreesia Named to Becker's Hospital Review's 2026 List of "Revenue Cycle Management Companies to Know"Phreesia, a leader in patient intake, outreach and activation, has been named to Becker's Hospital Review's 2026 list of "Revenue Cycle Management Companies to Know." The annual list recognizes companies that play a critical role in helping healthcare organizations manage the growing complexity of revenue cycle operations, including patient access, intake, billing and reimbursement. The 2026 list highlights organizations driving innovation and performance across the revenue cycle. Phreesia helps providers digitize intake and manage payment workflows before, during and after patient visits, improving collections and reducing manual administrative work. "We're honored to be recognized by
- INSIDERSEC Form 4 filed by Gandhi Balaji4 - Phreesia, Inc. (0001412408) (Issuer)
- INSIDERSEC Form 4 filed by Hoffman Allison C4 - Phreesia, Inc. (0001412408) (Issuer)
- INSIDERSEC Form 4 filed by Indig Chaim4 - Phreesia, Inc. (0001412408) (Issuer)
- INSIDERSEC Form 4 filed by Hui Yvonne4 - Phreesia, Inc. (0001412408) (Issuer)
- INSIDERSEC Form 4 filed by Roberts Evan4 - Phreesia, Inc. (0001412408) (Issuer)
PHR FAQ
7 questionsWhat does Phreesia Inc. do?
Phreesia, Inc. provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. Its Phreesia Platform offers a suite of solutions to manage the patient intake process, as well as an integrated payments solution for processing of patient payments. The company deploys its platform in a range of modalities, such as Phreesia Mobile, a patients' mobile device; Phreesia Dashboard, a Web-based dashboard for providers; PhreesiaPads, which are self-service intake tablets; and Arrivals Kiosks that are on-site kiosks. Its Phreesia Platform also...Where does PHR stock trade?
Phreesia Inc. (PHR) is listed on NYSE.What sector and industry is PHR in?
Phreesia Inc. operates in the Real Estate sector.When did Phreesia Inc. go public?
Phreesia Inc. (PHR) completed its IPO in 2019.What are analysts saying about PHR?
Phreesia Inc. has had 8 recent analyst actions on file. The most recent action was from Piper Sandler: Neutral with a $1200.00 price target on 2026-05-28. Recent price targets range from $900.00 to $1600.00.What companies are similar to PHR?
Notable peers in the same industry include V (Visa Inc.), MA (Mastercard Incorporated), BABA (Alibaba Group Holding Limited), UBER (Uber Technologies Inc.), ACN (Accenture plc). Compare PHR side-by-side with any of them on Quantisnow.How can I track PHR on Quantisnow?
Quantisnow aggregates Phreesia Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow PHR to receive live email and push alerts on every new disclosure.